Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 30, 2011 09:00 ET | Source: Marina Biotech, Inc.

Marina Biotech, Inc. to Present at the 10th Annual Needham Healthcare Conference

BOTHELL, WA--(Marketwire - March 30, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, announced today that it will present at the 10th Annual...
March 23, 2011 16:05 ET | Source: Marina Biotech, Inc.

Marina Biotech, Inc. Announces Fourth Quarter and Full Year 2010 Financial Results

BOTHELL, WA--(Marketwire - March 23, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today reported financial results for the fourth quarter...
March 16, 2011 16:30 ET | Source: Marina Biotech, Inc.

Marina Biotech, Inc. to Report Fourth Quarter and Year-End 2010 Results on March 23, 2011 at 4:30 p.m. Eastern Time

BOTHELL, WA--(Marketwire - March 16, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced that it will host a conference call with...
March 14, 2011 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Announces First Patient Enrollment in Familial Adenomatous Polyposis Clinical Trial

BOTHELL, WA--(Marketwire - March 14, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced enrollment of the first patient in...
March 08, 2011 09:00 ET | Source: Marina Biotech, Inc.

Marina Biotech, Inc. to Present at the ROTH 23rd Annual OC Growth Stock Conference

BOTHELL, WA--(Marketwire - March 8, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, announced today that it will present at the ROTH 23rd...
March 03, 2011 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Publishes Pre-Clinical Research on RNAi-Based Therapeutics Targeting Survivin and PLK1 in Bladder Cancer

BOTHELL, WA--(Marketwire - March 3, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, announced today publication of data, from their...
March 02, 2011 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Announces Significant Knockdown of a Cancer Target in a Rodent Model of Malignant Ascites

BOTHELL, WA--(Marketwire - March 2, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, reported data demonstrating significant knockdown of...
February 24, 2011 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Reports Interim Results of Their Phase 2-Enabling Toxicology Study for CEQ508

BOTHELL, WA--(Marketwire - February 24, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced that it has completed a 9 month...
February 14, 2011 08:30 ET | Source: Marina Biotech, Inc.

Marina Biotech Describes Integrated Technology Platform for the Development of RNAi-, microRNA- and Antisense-based Therapeutics

BOTHELL, WA--(Marketwire - February 14, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today presented their integrated technology platform...
February 10, 2011 09:00 ET | Source: Marina Biotech, Inc.

Marina Biotech Announces Pricing of Public Offering

BOTHELL, WA--(Marketwire - February 10, 2011) - Marina Biotech, Inc. (NASDAQ: MRNA), a leading RNAi-based drug discovery and development company, today announced the pricing of an underwritten public...